Nefazodone
- Generic Name
- Nefazodone
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C25H32ClN5O2
- CAS Number
- 83366-66-9
- Unique Ingredient Identifier
- 59H4FCV1TF
- Background
Nefazodone hydrochloride (trade name Serzone) is an antidepressant drug marketed by Bristol-Myers Squibb. Its sale was discontinued in 2003 in some countries, due to the small possibility of hepatic (liver) injury. Drug-induced hepatic injuries were associated with an risk of elevated need for a liver transplant, or even death, with the incidence of severe l...
- Indication
用于抑郁症的治疗。
- Associated Conditions
- Depression
- Associated Therapies
- -
Effectiveness of Nefazodone and Bupropion in Treating Marijuana Dependent Individuals
- Conditions
- First Posted Date
- 2005-11-07
- Last Posted Date
- 2017-01-16
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 132
- Registration Number
- NCT00249509
- Locations
- 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
Nefazodone in the Treatment of Social Phobia
- Conditions
- First Posted Date
- 2005-10-04
- Last Posted Date
- 2013-11-13
- Lead Sponsor
- Emory University
- Target Recruit Count
- 24
- Registration Number
- NCT00231348
- Locations
- 🇺🇸
Emory University Depatment of Psychiatry and Behavioral Sciences, Atlanta, Georgia, United States
Nefazodone in the Treatment of Cocaine Dependence and Depression - 4
- Conditions
- Interventions
- First Posted Date
- 2001-04-18
- Last Posted Date
- 2015-07-30
- Lead Sponsor
- Boston Medical Center
- Target Recruit Count
- 69
- Registration Number
- NCT00015210
- Locations
- 🇺🇸
Boston University, Boston, Massachusetts, United States
Effects of Nefazodone on Treatment of Female Cocaine Abusers - 3
- Conditions
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000286
- Locations
- 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
Effect of Nefazodone on Relapse in Females With Cocaine Abuse - 10
- Conditions
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000293
- Locations
- 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.